With the arrival of new tech, how we collect data for in-store execution is changing. This impacts the kinds of KPIs that companies track and how they derive insights from them.
Back in June we published the whitepaper “Why In-Store Execution Has Changed Forever – And What You Need To Do To Succeed.” How are things looking five months on?
It’s no news to you: the Covid-19 pandemic has posed a significant challenge to sales teams monitoring offline trade channels. Consumers are altering their behaviours and opting for different channels according to new restrictions. This shift in customer preferences has an immediate knock-on effect for in-store execution. Heads of Sales, must decide where to allocate resources to ensure that their perfect store strategies have the greatest impact.
As retail begins to readjust to the new way of life, the impact of the pandemic for in-store execution is becoming increasingly evident. While trends come and go, the past 6 months have prompted Sales Teams to radically rethink their perfect store strategies, adapting to restrictions and limitations in inventive ways.
Likewise other go-to-market strategies – Brand Recommendation (advice given by pharmacists on specific brands when consumers ask for a recommendation for medicine) is one of the most crucial elements for any pharmaceutical brand wishing to increase market penetration and sales, yet only a few manufacturers are actively focusing on implementing valuable strategies alongside this growth driver.
JUUL Labs, one of the world leaders in the field of electronic nicotine products, in partnership with BeMyEye, launched a large-scale program to check the age limits for the sale of electronic cigarettes in Russian retail. This is the latest step in JUUL Labs’ ongoing commitment in Russia to prevent the use of its products by anyone who is under 18, as it not only complies with local regulations but goes above and beyond to ensure industry-leading responsible practices.
Last week at the Nicholas Hall Group of Companies conference in Vienna, our CEO, Luca Pagano, presented the results of our latest pan-European study on Cold & Flu medicines.
The recommendation from a professional pharmacist is gold dust for a pharmaceutical brand wishing to increase market penetration and sales, yet few pharma manufacturers are aware of what the word on the street is when it comes to brand recommendations for common ailments.
Beginning in September 2013, Rapport had a specific need to support one of their global consumer electronics customers with a three-year campaign across 212 billboards in the UK. The client wished to see photographic evidence of all billboards in situ, as well as specific insights on their implementation.